Certain CBD compound prevents COVID cells from replicating, studies show
Recently published studies researching the effects of cannabidiol (CBD) on human and mice suggest that the primary active compound in hemp and marijuana may prevent SARS-COV-2, the virus that causes COVID-19, replication early in the course of COVID infection.
According to one study published by the National Institute of Health, the active metabolite in CBD, 7-OH-CBD, acts after cellular infection, inhibiting gene expression and reversing many effects of SARS-COV-2, preventing the infection from worsening and promoting future immunity.
A separate study from the 2022 American Chemical Society and American Society of Pharmacognosy found that two cannabinoid acids bind to spike proteins of SARS-COV-2, preventing the virus from entering cells and causing infection. Health experts are hopeful that this research will open new doors into treatment and prevention for COVID-19 infection.
Charleston Hemp Collective, a local CBD business, is adding the Wellness Warrior tincture to its product lineup, which contains a 1:1:1:1 ratio of a blend of cannabinoids, two of which were the acids researched in the 2022 study.
Latest COVID-19 data
South Carolina health officials on Jan. 21 reported 13,898 new total cases of COVID-19 with 8,896 confirmed. A total of 24 new deaths, 19 of which are confirmed, were also reported.
With 45,132 tests reported Friday, 32.9% were confirmed positive.
Percentage of S.C. residents age 12+ with at least one vaccine: 66.2%
Percentage of S.C. residents age 12+ who have completed vaccination: 56.9%
Percentage of S.C. residents age 5-11 with at least one vaccine: 16.3%
Percentage of S.C. residents age 5-11 who have completed vaccination: 10.3%
Help keep the City Paper free.
No paywalls.
No subscription cost.
Free delivery at 800 locations.
Help support independent journalism by donating today.